105 related articles for article (PubMed ID: 11866977)
1. [Activation of p38 and c-Jun NH2-terminal kinase mitogen-activated protein kinases in human prostate carcinoma cell lines with different metastatic potentials].
Li H; Fang W; He C; You J; Heng W; Zheng J; Wu B
Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):194-7. PubMed ID: 11866977
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of the activation of extracellular signal-regulated kinase (ERK) in prostate cancer cell lines with different metastatic potential].
Li H; He C; Zheng J
Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(4):197-200. PubMed ID: 11798872
[TBL] [Abstract][Full Text] [Related]
3. [SHP2 and MKP5 in P2Y purinergic receptor-mediated prostate cancer invasion].
He HY; Zheng J; Li Y; Heng WJ; Fang WG
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):288-92. PubMed ID: 16181551
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of the mitogen-activated protein kinase phosphatase-5 regulating the growth and invasion of a human prostate cancer cell line].
He HY; Fang WG; Zheng J; You JF; Heng WJ; Li Y
Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1812-7. PubMed ID: 14642090
[TBL] [Abstract][Full Text] [Related]
5. [Effects of P2Y receptor activation on prostatic cancer cells requiring ERK1/2 or p38 cascade].
Chen L; Fang WG; Heng WJ; You JF
Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):146-50. PubMed ID: 15132853
[TBL] [Abstract][Full Text] [Related]
6. [ERK1/2 and p38 kinases are important regulators in P2Y receptor-mediated prostate cancer invasion].
Chen L; He HY; Li HM; You JF; Heng WJ; Li Y; Fang WG
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):111-4. PubMed ID: 15774218
[TBL] [Abstract][Full Text] [Related]
7. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
[TBL] [Abstract][Full Text] [Related]
8. Activation of the p38 and p42/p44 mitogen-activated protein kinase families by the histamine H(1) receptor in DDT(1)MF-2 cells.
Robinson AJ; Dickenson JM
Br J Pharmacol; 2001 Aug; 133(8):1378-86. PubMed ID: 11498525
[TBL] [Abstract][Full Text] [Related]
9. Extracellular nucleotides activate the p38-stress-activated protein kinase cascade in glomerular mesangial cells.
Huwiler A; Wartmann M; van den Bosch H; Pfeilschifter J
Br J Pharmacol; 2000 Feb; 129(3):612-8. PubMed ID: 10711362
[TBL] [Abstract][Full Text] [Related]
10. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer.
Joo SS; Yoo YM
J Pineal Res; 2009 Aug; 47(1):8-14. PubMed ID: 19522739
[TBL] [Abstract][Full Text] [Related]
11. Differential role for mitogen-activated protein kinases in IgE-dependent signaling in human peripheral blood basophils: in contrast to p38 MAPK, c-Jun N-terminal kinase is poorly expressed and does not appear to control mediator release.
Gibbs BF; Wolff HH; Zillikens D; Grabbe J
Int Arch Allergy Immunol; 2005 Apr; 136(4):329-39. PubMed ID: 15741731
[TBL] [Abstract][Full Text] [Related]
12. c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) are involved in Mycobacterium tuberculosis-induced expression of Leukotactin-1.
Cho JE; Park S; Cho SN; Lee H; Kim YS
BMB Rep; 2012 Oct; 45(10):583-8. PubMed ID: 23101513
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.
Mhaidat NM; Zhang XD; Jiang CC; Hersey P
Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842
[TBL] [Abstract][Full Text] [Related]
14. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation.
MacFarlane M; Cohen GM; Dickens M
Biochem J; 2000 May; 348 Pt 1(Pt 1):93-101. PubMed ID: 10794718
[TBL] [Abstract][Full Text] [Related]
15. IKappaB-kinase/nuclear factor-kappaB signaling prevents thermal injury-induced gut damage by inhibiting c-Jun NH2-terminal kinase activation.
Chen LW; Chen PH; Chang WJ; Wang JS; Karin M; Hsu CM
Crit Care Med; 2007 May; 35(5):1332-40. PubMed ID: 17414734
[TBL] [Abstract][Full Text] [Related]
16. p38 Mitogen-activated protein kinase and c-Jun NH2-terminal protein kinase regulate the accumulation of a tight junction protein, ZO-1, in cell-cell contacts in HaCaT cells.
Minakami M; Kitagawa N; Iida H; Anan H; Inai T
Tissue Cell; 2015 Feb; 47(1):1-9. PubMed ID: 25435485
[TBL] [Abstract][Full Text] [Related]
17. Antiepileptic action of c-Jun N-terminal kinase (JNK) inhibition in an animal model of temporal lobe epilepsy.
Tai TY; Warner LN; Jones TD; Jung S; Concepcion FA; Skyrud DW; Fender J; Liu Y; Williams AD; Neumaier JF; D'Ambrosio R; Poolos NP
Neuroscience; 2017 May; 349():35-47. PubMed ID: 28237815
[TBL] [Abstract][Full Text] [Related]
18. [P2Y purinergic receptor activated PI-3K/Akt signaling pathway in regulation of growth and invasion of prostatic cancer].
Wang YX; Shi YH; Gong LH; Li Y; Heng WJ; You JF; Zhong HH; Fang WG
Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):681-6. PubMed ID: 18194602
[TBL] [Abstract][Full Text] [Related]
19. Stimulation by extracellular ATP and UTP of the stress-activated protein kinase cascade in rat renal mesangial cells.
Huwiler A; van Rossum G; Wartmann M; Pfeilschifter J
Br J Pharmacol; 1997 Mar; 120(5):807-12. PubMed ID: 9138685
[TBL] [Abstract][Full Text] [Related]
20. Activation of p38 mitogen-activated protein kinase (p38 MAPK), extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK) during hypoxia in cerebral cortical nuclei of guinea pig fetus at term: role of nitric oxide.
Maulik D; Ashraf QM; Mishra OP; Delivoria-Papadopoulos M
Neurosci Lett; 2008 Jul; 439(1):94-9. PubMed ID: 18511197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
